Artificial Neural Networks Analysis Used to Evaluate the Molecular Interactions between Selected Drugs and Human Cyclooxygenase2 Receptor

Objective(s): A fast and reliable evaluation of the binding energy from a single conformation of a molecular complex is an important practical task. Artificial neural networks (ANNs) are strong tools for predicting nonlinear functions which are used in this paper to predict binding energy. We proposed a structure that obtains binding energy using physicochemical molecular descriptions of the selected drugs. Material and Methods: The set of 33 drugs with their binding energy to cyclooxygenase enzyme (COX2) in hand, from different structure groups, were considered. 27 physicochemical property descriptors were calculated by standard molecular modeling. Binding energy was calculated for each compound through docking and also ANN. A multi-layer perceptron neural network was used. Results: The proposed ANN model based on selected molecular descriptors showed a high degree of correlation between binding energy observed and calculated. The final model possessed a 27-4-1 architecture and correlation coefficients for learning, validating and testing sets equaled 0.973, 0.956 and 0.950, respectively. Conclusion: Results show that docking results and ANN data have a high correlation. It was shown that ANN is a strong tool for prediction of the binding energy and thus inhibition constants for different drugs in very short periods of time.

[1]  Fevzullah Temurtas,et al.  A comparative study on diabetes disease diagnosis using neural networks , 2009, Expert Syst. Appl..

[2]  A. Buciński,et al.  Artificial neural networks analysis used to evaluate the molecular interactions between selected drugs and human alpha1-acid glycoprotein. , 2009, Journal of pharmaceutical and biomedical analysis.

[3]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[4]  Mire Zloh,et al.  Prediction of aqueous solubility of drug-like molecules using a novel algorithm for automatic adjustment of relative importance of descriptors implemented in counter-propagation artificial neural networks. , 2012, International journal of pharmaceutics.

[5]  Xueguang Shao,et al.  Protein-ligand recognition using spherical harmonic molecular surfaces: towards a fast and efficient filter for large virtual throughput screening. , 2002, Journal of molecular graphics & modelling.

[6]  Shigeo Yamamura,et al.  Clinical application of artificial neural network (ANN) modeling to predict pharmacokinetic parameters of severely ill patients. , 2003, Advanced drug delivery reviews.

[7]  K. Asadpour‐Zeynali,et al.  Modeling drug solubility in water-cosolvent mixtures using an artificial neural network. , 2004, Farmaco.

[8]  Mohammad S. Iqbal,et al.  A QSPR study of drug release from an arabinoxylan using ab initio optimization and neural networks , 2012 .

[9]  Charles L. Brooks,et al.  Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures , 2004, J. Comput. Chem..

[10]  W. Richard Bowen,et al.  DYNAMIC ULTRAFILTRATION OF PROTEINS-A NEURAL NETWORK APPROACH , 1998 .

[11]  J. V. Turner,et al.  Pharmacokinetic parameter prediction from drug structure using artificial neural networks. , 2004, International journal of pharmaceutics.

[12]  J. Huuskonen,et al.  Estimation of Aqueous Solubility for a Diverse Set of Organic Compounds Based on Molecular Topology. , 2010 .

[13]  S. Agatonovic-Kustrin,et al.  Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. , 2000, Journal of pharmaceutical and biomedical analysis.

[14]  Brian B. Goldman,et al.  QSD quadratic shape descriptors. 2. Molecular docking using quadratic shape descriptors (QSDock) , 2000, Proteins.

[15]  Thomas Lengauer,et al.  Computational methods for biomolecular docking. , 1996, Current opinion in structural biology.

[16]  Jin Park,et al.  A sequential neural network model for diabetes prediction , 2001, Artif. Intell. Medicine.

[17]  Firat Hardalaç,et al.  Classification of carotid artery stenosis of patients with diabetes by neural network and logistic regression , 2004, Comput. Biol. Medicine.

[18]  GuanHua Chen,et al.  A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors. , 2006, Journal of molecular graphics & modelling.

[19]  Janet M. Thornton,et al.  Real spherical harmonic expansion coefficients as 3D shape descriptors for protein binding pocket and ligand comparisons , 2005, Bioinform..